TOX4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.569800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.437600E-01
Normal-vs-Stage2
8.902400E-01
Normal-vs-Stage3
1.352420E-01
Normal-vs-Stage4
5.301000E-01
Stage1-vs-Stage2
6.344600E-01
Stage1-vs-Stage3
1.890760E-01
Stage1-vs-Stage4
2.279800E-01
Stage2-vs-Stage3
8.932500E-02
Stage2-vs-Stage4
1.621850E-01
Stage3-vs-Stage4
1.214610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.485200E-01
Normal-vs-AfricanAmerican
9.189200E-01
Normal-vs-Asian
6.326400E-01
Caucasian-vs-AfricanAmerican
9.516600E-01
Caucasian-vs-Asian
5.446200E-01
AfricanAmerican-vs-Asian
7.110000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.634000E-01
Normal-vs-Female
8.499400E-01
Male-vs-Female
9.510800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.062600E-01
Normal-vs-Age(41-60Yrs)
6.206600E-01
Normal-vs-Age(61-80Yrs)
6.060800E-01
Normal-vs-Age(81-100Yrs)
8.485600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.182800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.285200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.565800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.636700E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.085000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.919800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.395200E-01
Normal-vs-Daily Drinker
7.243200E-01
Normal-vs-Weekly Drinker
6.699400E-01
Normal-vs-Occasional Drinker
6.588800E-01
Normal-vs-Social Drinker
9.945400E-01
Non Drinker-vs-Daily Drinker
4.751400E-01
Non Drinker-vs-Weekly Drinker
6.742000E-01
Non Drinker-vs-Occasional Drinker
1.904020E-02
Non Drinker-vs-Social Drinker
1.453040E-01
Daily Drinker-vs-Weekly Drinker
8.625600E-01
Daily Drinker-vs-Occasional Drinker
1.429960E-01
Daily Drinker-vs-Social Drinker
4.976200E-01
Weekly Drinker-vs-Occasional Drinker
1.462390E-01
Weekly Drinker-vs-Social Drinker
4.376800E-01
Occasional Drinker-vs-Social Drinker
4.359400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.825600E-01
Normal-vs-Grade 2
6.121800E-01
Normal-vs-Grade 3
5.623200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.567800E-01
Grade 1-vs-Grade 3
6.673600E-02
Grade 1-vs-Grade 4
2.825600E-01
Grade 2-vs-Grade 3
2.255400E-01
Grade 2-vs-Grade 4
6.121800E-01
Grade 3-vs-Grade 4
5.623200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.032200E-01
Normal-vs-NonDiabetic
7.699600E-01
Diabetic-vs-NonDiabetic
7.470600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.940600E-01
Normal-vs-NoPancreatitis
7.930600E-01
Pancreatitis-vs-NoPancreatitis
4.968200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.550000E-01
Normal-vs-N1
9.003800E-01
N0-vs-N1
5.440200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.725600E-01
Normal-vs-TP53-NonMutant
8.586400E-01
TP53-Mutant-vs-TP53-NonMutant
1.265650E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
